Concepedia

James V. Cassella

JV

Statistics

Publications

43

Citations

2.2K

H-Index

28

Active since

1983

Affiliations

Alexza Pharmaceuticals (United States)(Current)

Yale University

Connecticut Mental Health Center

University of California, Irvine

Teva Pharmaceuticals (United States)

James V. Cassella is an author at Alexza Pharmaceuticals (United States) specializing in medicine, pharmacology, and neuropharmacology.

ORCID

Top concepts

Publications per year

1983–2024

43

Publications

43

Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine

Michael D. Lesem, Tram Tran-Johnson, Robert Riesenberg et al. · The British Journal of Psychiatry · 2011 · 153 citations · Full text

The design and calibration of a startle measurement system

James V. Cassella, Michael T. Davis · Physiology & Behavior · 1986 · 142 citations

, , +8

Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo‐controlled clinical trial with inhaled loxapine

Joseph A. Kwentus, Robert Riesenberg, Morteza Marandi et al. · Bipolar Disorders · 2012 · 124 citations

Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia

Michael H. Allen, David Feifel, Michael D. Lesem et al. · The Journal of Clinical Psychiatry · 2011 · 99 citations

The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801

Diane C. Hoffman, Hilary Donovan, James V. Cassella · Psychopharmacology · 1993 · 98 citations

, , +10

1–5 of 43